Department of Gastroenterological Surgery II, Faculty of Medicine, Hokkaido University, Sapporo, Hokkaido, Japan.
Clinical Research and Medical Innovation Centre, Hokkaido University Hospital, Sapporo, Japan.
Ann Surg Oncol. 2020 Oct;27(11):4171-4180. doi: 10.1245/s10434-020-08534-2. Epub 2020 May 3.
The differences between perihilar cholangiocarcinoma (PHCC) and distal cholangiocarcinoma (DCC) regarding recurrence and the factors that affect recurrence after surgery are unclear. This study aims to investigate the differences in recurrence patterns between patients with PHCC and those with DCC after surgical resection with curative intent. It also investigates the risk factors associated with recurrence and survival thereafter.
The postoperative courses of 366 patients with extrahepatic cholangiocarcinomas (EHCCs), including 236 with PHCC and 130 with DCC, who underwent surgical resections were investigated retrospectively.
During follow-up, tumors recurred in 143 (60.6%) patients with PHCC and in 72 (55.4%) patients with DCC. Overall survival (OS) after surgery, recurrence-free survival (RFS), and OS after recurrence were similar for the patients with PHCC and those with DCC. The cumulative probability of recurrence declined 3 years after surgery in the patients with PHCC and those with DCC. A multivariable analysis determined that, among the patients with PHCC and those with DCC, regional lymph node metastasis was a significant risk factor associated with RFS. Ten patients with PHCC and eight patients with DCC with two or fewer sites of recurrence in a single organ underwent resections. A multivariable analysis determined that recurrent tumor resection was an independent prognostic factor associated with OS after recurrence in the patients with PHCC and those with DCC.
Postoperative survival did not differ between the patients with PHCC and those with DCC. Frequent surveillances for recurrence are needed for 3 years after surgical resection of EHCCs. In selected patients, surgery for recurrent EHCCs might be associated with improved outcomes.
肝门部胆管癌(PHCC)和远端胆管癌(DCC)患者在术后复发方面存在差异,且影响术后复发的因素也不明确。本研究旨在探讨根治性手术切除后 PHCC 患者与 DCC 患者复发模式的差异,并分析与复发及此后生存相关的危险因素。
回顾性分析 366 例接受肝外胆管癌(EHCC)根治性切除术患者的术后病程,其中 236 例为 PHCC 患者,130 例为 DCC 患者。
在随访期间,PHCC 患者中有 143 例(60.6%)和 DCC 患者中有 72 例(55.4%)肿瘤复发。PHCC 患者和 DCC 患者的手术总生存(OS)、无复发生存(RFS)和复发后 OS 相似。PHCC 患者和 DCC 患者的累积复发概率在术后 3 年下降。多变量分析确定,在 PHCC 患者和 DCC 患者中,区域淋巴结转移是与 RFS 相关的显著危险因素。10 例 PHCC 患者和 8 例 DCC 患者中,在单一器官内有两个或更少部位的复发病灶,接受了切除术。多变量分析确定,在 PHCC 患者和 DCC 患者中,复发性肿瘤切除术是与复发后 OS 相关的独立预后因素。
PHCC 患者和 DCC 患者的术后生存无差异。在 EHCC 根治性切除术后的 3 年内需要频繁监测复发情况。在选择的患者中,复发性 EHCC 的手术可能与改善结局相关。